GB2306470B
(en )
1999-11-03
Reactive liquid crystalline compound
HK1023125A1
(en )
2000-09-01
Crystalline form of 4-Ä5-methyl-3-phenylisoxazol-4-ylÜbenzenesulfonamide
SG71006A1
(en )
2000-03-21
Fabrication process of soi substrate
AU6772996A
(en )
1997-03-12
2-acylaminopropanamides as growth hormone secretagogues
PL321590A1
(en )
1997-12-08
Compounds capable to cause liberation of the growth hormone
PL327438A1
(en )
1998-12-07
Transgenous plant of altered ageing characteristic
GB9511935D0
(en )
1995-08-09
Novel compound
ZA969753B
(en )
1997-03-25
Crystalline hydrochloride of (r)-(-)-2-än-4-(1,1-dioxido-3-oxo-2,3-dihydrobenzhisothiazol-2-yl)-aminomethylü-chroman
IL141433A0
(en )
2002-03-10
Crystalline forms of eto2c-ch2- (r) cgl-aze-pab-oh
AU6724496A
(en )
1997-03-12
2-acylaminopropanamines as growth hormone secretagogues
ZA965234B
(en )
1997-03-06
Bioavailable crystalline form of cefuroxime exetil
EP0750058A3
(en )
1997-08-27
Doping of crystalline substrates
AU4953796A
(en )
1996-10-02
Dipeptide compounds having ahpba structure
AU7020296A
(en )
1997-04-24
Timepiece
EP0735125A3
(en )
1997-07-23
Liquid crystalline allenes
EP0733725A3
(en )
1997-05-07
Growth of silicon single crystal
PL337612A1
(en )
2000-08-28
Crystalline form of roxyfiban
AU4453396A
(en )
1996-07-31
Growth factor analogs
ZA965026B
(en )
1997-01-23
Doping of crystalline substrates
AU6127096A
(en )
1997-01-22
Solar geo-stellar planisphere
GB2326648B
(en )
1999-09-22
Growth method of polycrystal silicon film
AU4941900A
(en )
2000-12-18
Doping of crystalline substrates
AU4659196A
(en )
1996-07-31
Methods of inhibiting growth hormone effects
PL325602A1
(en )
1998-08-03
Alternative crystalline form of thazophenelone
AU4649996A
(en )
1997-07-28
Quranic watch